Gelteq Limited stock jumps in premarket after CBD gel study; what’s next for GELS
NEW YORK, Jan 14, 2026, 08:42 AM EST — Premarket Gelteq Limited shares surged roughly 48% to $1.23 in premarket action Wednesday, following a 6.4% gain at Tuesday’s close. (StockAnalysis) The Nasdaq-listed biotech revealed that a recent preclinical study demonstrated its ingestible gel delivery platform boosts cannabidiol (CBD) absorption over an FDA-approved oil-based option. Gelteq also indicated these findings might…